Pearse A Keane1, Konstantinos Balaskas2, Dawn A Sim1, Kiran Aman2, Alastair K Denniston3, Tariq Aslam4. 1. NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK. 2. Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. 3. Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK ; Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK ; Birmingham & Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK. 4. Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK ; Faculty of Medical and Human Sciences, University of Manchester, UK ; School of Built Environment, Herriot-Watt University, UK.
Abstract
PURPOSE: To develop an automated method for quantifying vitreous signal intensity on optical coherence tomography (OCT), with particular application for use in the assessment of vitreous inflammation. METHODS: This retrospective, observational case-control series comprised 30 patients (30 eyes), with vitreous haze secondary to intermediate, posterior, or panuveitis; 12 patients (12 eyes) with uveitis without evidence of vitreous haze; and 18 patients (18 eyes) without intraocular inflammation or vitreoretinal disease. The presence and severity of vitreous haze was classified according to the National Eye Institute system; other inflammatory indices and clinical parameters were also documented. Spectral-domain OCT images were analyzed using custom VITreous ANalysis software (termed 'VITAN'), which is fully automated and avoids the need for manual segmentation. RESULTS: VITAN performed accurate segmentation in all scans. Automated measurements of the vitreous:retinal pigment epithelium (RPE) signal ratio showed a moderate correlation with clinical vitreous haze scores (r = 0.585, P < 0.001), comparable to that reported using manual segmentation in our previous study (r = 0.566, P = 0.0001). The novel parameter of vitreous:RPE textural ratio showed a marginally stronger correlation (r = 0.604, P < 0.001) with clinical vitreous haze scores than the Vitreous:RPE signal ratio. CONCLUSIONS: The custom OCT image analysis software (VITAN) allows rapid and automated measurement of vitreous parameters, that is comparable to our previously reported vitreous:RPE index, and correlates with clinically measured disease activity. Such OCT-based indices may provide the much needed objective markers of vitreous activity, which may be used in both clinical assessment, and as outcome measures in clinical trials for intermediate, posterior, and panuveitis. TRANSLATIONAL RELEVANCE: We describe a rapid automated method for quantifying vitreous signal intensity on optical coherence tomography (OCT) and show that this correlates with clinical assessment of vitreous inflammation. Such OCT-based indices may provide the much needed objective markers of vitreous activity, which may be used both in routine clinical assessment, and as outcome measures in clinical trials for intermediate, posterior, and panuveitis.
PURPOSE: To develop an automated method for quantifying vitreous signal intensity on optical coherence tomography (OCT), with particular application for use in the assessment of vitreous inflammation. METHODS: This retrospective, observational case-control series comprised 30 patients (30 eyes), with vitreous haze secondary to intermediate, posterior, or panuveitis; 12 patients (12 eyes) with uveitis without evidence of vitreous haze; and 18 patients (18 eyes) without intraocular inflammation or vitreoretinal disease. The presence and severity of vitreous haze was classified according to the National Eye Institute system; other inflammatory indices and clinical parameters were also documented. Spectral-domain OCT images were analyzed using custom VITreous ANalysis software (termed 'VITAN'), which is fully automated and avoids the need for manual segmentation. RESULTS: VITAN performed accurate segmentation in all scans. Automated measurements of the vitreous:retinal pigment epithelium (RPE) signal ratio showed a moderate correlation with clinical vitreous haze scores (r = 0.585, P < 0.001), comparable to that reported using manual segmentation in our previous study (r = 0.566, P = 0.0001). The novel parameter of vitreous:RPE textural ratio showed a marginally stronger correlation (r = 0.604, P < 0.001) with clinical vitreous haze scores than the Vitreous:RPE signal ratio. CONCLUSIONS: The custom OCT image analysis software (VITAN) allows rapid and automated measurement of vitreous parameters, that is comparable to our previously reported vitreous:RPE index, and correlates with clinically measured disease activity. Such OCT-based indices may provide the much needed objective markers of vitreous activity, which may be used in both clinical assessment, and as outcome measures in clinical trials for intermediate, posterior, and panuveitis. TRANSLATIONAL RELEVANCE: We describe a rapid automated method for quantifying vitreous signal intensity on optical coherence tomography (OCT) and show that this correlates with clinical assessment of vitreous inflammation. Such OCT-based indices may provide the much needed objective markers of vitreous activity, which may be used both in routine clinical assessment, and as outcome measures in clinical trials for intermediate, posterior, and panuveitis.
Authors: Pearse A Keane; Musarrat Allie; Stephen J Turner; H Sue Southworth; Srinivas R Sadda; Philip I Murray; Alastair K Denniston Journal: JAMA Ophthalmol Date: 2013-03 Impact factor: 7.389
Authors: Sandra Joeres; Jerry W Tsong; Paul G Updike; Allyson T Collins; Laurie Dustin; Alexander C Walsh; Peggy W Romano; SriniVas R Sadda Journal: Invest Ophthalmol Vis Sci Date: 2007-09 Impact factor: 4.799
Authors: Reena Chopra; Pádraig J Mulholland; Adam M Dubis; Roger S Anderson; Pearse A Keane Journal: Transl Vis Sci Technol Date: 2017-08-15 Impact factor: 3.283
Authors: D Coric; G Ometto; G Montesano; P A Keane; L J Balk; B M J Uitdehaag; A Petzold; D P Crabb; A K Denniston Journal: Eur J Neurol Date: 2019-08-18 Impact factor: 6.089
Authors: Shereen H Aboul Naga; Lameece Moustafa Hassan; Radwa T El Zanaty; Mohammad Refaat; Rana H Amin; Gaafar Ragab; Mahmoud M Soliman Journal: Front Med (Lausanne) Date: 2022-09-07
Authors: Christopher L Passaglia; Tia Arvaneh; Erin Greenberg; David Richards; Brian Madow Journal: Transl Vis Sci Technol Date: 2018-03-23 Impact factor: 3.283
Authors: Lydia J Bradley; Amy Ward; Madeleine C Y Hsue; Jian Liu; David A Copland; Andrew D Dick; Lindsay B Nicholson Journal: Front Immunol Date: 2021-06-18 Impact factor: 7.561
Authors: Axel Petzold; Philipp Albrecht; Laura Balcer; Erik Bekkers; Alexander U Brandt; Peter A Calabresi; Orla Galvin Deborah; Jennifer S Graves; Ari Green; Pearse A Keane; Jenny A Nij Bijvank; Josemir W Sander; Friedemann Paul; Shiv Saidha; Pablo Villoslada; Siegfried K Wagner; E Ann Yeh Journal: Ann Clin Transl Neurol Date: 2021-05-19 Impact factor: 4.511
Authors: G Montesano; C M Way; G Ometto; H Ibrahim; P R Jones; R Carmichael; X Liu; T Aslam; P A Keane; D P Crabb; A K Denniston Journal: Sci Rep Date: 2018-01-26 Impact factor: 4.379
Authors: María Jesús Rodrigo; Manuel Subías; Alberto Montolío; Silvia Méndez-Martínez; Teresa Martínez-Rincón; Lorena Arias; David García-Herranz; Irene Bravo-Osuna; Julian Garcia-Feijoo; Luis Pablo; José Cegoñino; Rocio Herrero-Vanrell; Ana Carretero; Jesus Ruberte; Elena Garcia-Martin; Amaya Pérez Del Palomar Journal: Biomedicines Date: 2021-11-29
Authors: Xiaoxuan Liu; Benjamin Tk Hui; Christopher Way; Sophie Beese; Ada Adriano; Pearse A Keane; David J Moore; Alastair K Denniston Journal: Ocul Immunol Inflamm Date: 2020-10-06 Impact factor: 3.070